Overview

Actigraphy Improvement With Voxelotor (ActIVe) Study

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the effect of voxelotor on daily physical activity and sleep quality, as measured by a wrist-worn device in participants with sickle cell disease (SCD) and chronic moderate anemia.
Phase:
Phase 4
Details
Lead Sponsor:
Global Blood Therapeutics